HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Linear IgA Bullous Dermatosis D062027 1 associated lipids
Odontogenic Cyst, Calcifying D018333 1 associated lipids
Neoplasms, Connective and Soft Tissue D018204 1 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Sarcoma, Endometrial Stromal D018203 1 associated lipids
Prostatic Intraepithelial Neoplasia D019048 1 associated lipids
Rhabdomyoma D012207 1 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Chu LC et al. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats. 2011 Br J Anaesth pmid:21441243
Ribeiro PO et al. Apoptotic neurodegeneration and spatial memory are not affected by sedative and anaesthetics doses of ketamine/medetomidine combinations in adult mice. 2012 Br J Anaesth pmid:22362669
Li Y et al. Human uveal melanoma expresses NG2 immunoreactivity. 2003 Br J Ophthalmol pmid:12714409
Sjö LD et al. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. 2006 Br J Ophthalmol pmid:16672329
Tulvatana W et al. Risk factors for conjunctival squamous cell neoplasia: a matched case-control study. 2003 Br J Ophthalmol pmid:12642297
Shimmura S et al. Microkeratome assisted deep lamellar keratoprosthesis. 2006 Br J Ophthalmol pmid:16597665
Thinda S et al. Polycarbonate membrane impression cytology: evidence for fluorescein staining in normal and dry eye corneas. 2010 Br J Ophthalmol pmid:20424211
Sawa M et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. 2004 Br J Ophthalmol pmid:15148220
Smith JR et al. Expression of vascular endothelial growth factor and its receptors in rosacea. 2007 Br J Ophthalmol pmid:17244661
Crosby MB et al. Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. 2011 Br J Ophthalmol pmid:20819828
Schnurrbusch UE et al. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. 2001 Br J Ophthalmol pmid:11520762
Delarive T et al. Aqueous dynamic and histological findings after deep sclerectomy with collagen implant in an animal model. 2003 Br J Ophthalmol pmid:14609829
Marback EF et al. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. 2003 Br J Ophthalmol pmid:14507753
Dua HS et al. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. 2005 Br J Ophthalmol pmid:15834076
Sheidow TG et al. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. 2000 Br J Ophthalmol pmid:10873988
Touhami A et al. Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia. 2005 Br J Ophthalmol pmid:15722301
Shimmura S et al. Transplantation of corneal endothelium with Descemet's membrane using a hyroxyethyl methacrylate polymer as a carrier. 2005 Br J Ophthalmol pmid:15665339
Kim SG et al. Histological changes in the temporomandibular joint in rabbits depending on the extent of mandibular lengthening by osteodistraction. 2004 Br J Oral Maxillofac Surg pmid:15544889
Varley I et al. Pinning out pathological specimens--are we risking an unnecessary escalation of treatment? 2015 Br J Oral Maxillofac Surg pmid:25799957
Umeda M et al. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice. 2001 Br J Oral Maxillofac Surg pmid:11601820
Ma Y and Shen G Distraction osteogenesis after irradiation in rabbit mandibles. 2012 Br J Oral Maxillofac Surg pmid:22079566
Topping A et al. Successful reduction in skin damage resulting from exposure to the normal-mode ruby laser in an animal model. 2001 Br J Plast Surg pmid:11207126
Nayak BB et al. A microneurovascular study of the great saphenous vein in man and the possible implications for survival of venous flaps. 2000 Br J Plast Surg pmid:10738330
Leslie TA et al. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? 2008 Br J Radiol pmid:18559903
Luo B et al. Neuroradiological findings of intracranial schwannomas not arising from the stems of cranial nerves. 2004 Br J Radiol pmid:15569643
Chong S et al. Herpes simplex virus pneumonia: high-resolution CT findings. 2010 Br J Radiol pmid:20442279
Longo UG et al. Characteristics at haematoxylin and eosin staining of ruptures of the long head of the biceps tendon. 2009 Br J Sports Med pmid:18070808
Cahill RA et al. Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. 2004 Br J Surg pmid:15505871
Noguchi M Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. 2002 Br J Surg pmid:12445058
Arai K et al. Clinicopathological analysis of early gastric cancer with solitary lymph node metastasis. 2002 Br J Surg pmid:12390388
Salem AA et al. Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. 2002 Br J Surg pmid:12390378
Smidt ML et al. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. 2002 Br J Surg pmid:12296899
Mizuno T et al. Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater. 2006 Br J Surg pmid:16363020
Motomura K et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. 2002 Br J Surg pmid:12153631
Osugi H et al. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. 2002 Br J Surg pmid:12081742
Braat AE et al. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. 2005 Br J Surg pmid:16231281
Noguchi M Sentinel lymph node biopsy and breast cancer. 2002 Br J Surg pmid:11851659
Rusby JE et al. Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. 2008 Br J Surg pmid:18844271
van Wely BJ et al. False-negative sentinel lymph node biopsy. 2008 Br J Surg pmid:18844270
Crombie N et al. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. 2001 Br J Surg pmid:11578285
Shrikhande SV et al. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis. 2003 Br J Surg pmid:14648737
Dhar DK et al. Prognostic significance of metastatic lymph node size in patients with gastric cancer. 2003 Br J Surg pmid:14648731
Wijeyaratne SM et al. Differences in the detection of cyclo-oxygenase 1 and 2 proteins in symptomatic and asymptomatic carotid plaques. 2001 Br J Surg pmid:11442526
Mofidi R et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. 2001 Br J Surg pmid:11442525
Nos C et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. 2003 Br J Surg pmid:14598414
Gruber G et al. Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. 2005 Br. J. Cancer pmid:15597101
Konishi N et al. Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas. 2003 Br. J. Cancer pmid:12698188
Takizawa S et al. Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer. 2003 Br. J. Cancer pmid:12698186
Barshack I et al. Spectral morphometric characterization of breast carcinoma cells. 1999 Br. J. Cancer pmid:10188915
Ouyang N et al. Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. 2010 Br. J. Cancer pmid:20531417
Chinje EC et al. 17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response. 2002 Br. J. Cancer pmid:11857025
Bjørge T et al. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. 2004 Br. J. Cancer pmid:15477862
Faneyte IF et al. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. 2003 Br. J. Cancer pmid:12569384
Martinelli M et al. Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel. 2007 Br. J. Cancer pmid:17848949
Koukourakis MI et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. 2003 Br. J. Cancer pmid:12942121
Lawson JS et al. Koilocytes indicate a role for human papilloma virus in breast cancer. 2009 Br. J. Cancer pmid:19773762
Semba S et al. Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells. 2009 Br. J. Cancer pmid:19773759
Phatak P et al. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. 2007 Br. J. Cancer pmid:17406367
Somlo G et al. Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. 2002 Br. J. Cancer pmid:12177795
Volm M et al. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. 2002 Br. J. Cancer pmid:12177790
Batistatou A et al. Involvement of dysadherin and E-cadherin in the development of testicular tumours. 2005 Br. J. Cancer pmid:16333245
Martinho O et al. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. 2009 Br. J. Cancer pmid:19707201
Foster CS et al. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. 2009 Br. J. Cancer pmid:19707199
Hofman P et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. 2008 Br. J. Cancer pmid:18268492
Gibcus JH et al. Cortactin expression predicts poor survival in laryngeal carcinoma. 2008 Br. J. Cancer pmid:18268491
McCallum M et al. A prognostic index for operable, node-negative breast cancer. 2004 Br. J. Cancer pmid:15138474
Matsuyoshi S et al. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. 2006 Br. J. Cancer pmid:16450001
Hart CA et al. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. 2002 Br. J. Cancer pmid:11953862
Koike C et al. Solid stress facilitates spheroid formation: potential involvement of hyaluronan. 2002 Br. J. Cancer pmid:11953828
Killeen SD et al. Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, WXC-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases. 2007 Br. J. Cancer pmid:17242699
Kölby L et al. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. 2005 Br. J. Cancer pmid:16251870
Koelink PJ et al. Clinical significance of stromal apoptosis in colorectal cancer. 2009 Br. J. Cancer pmid:19654576
Michel S et al. High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. 2008 Br. J. Cancer pmid:18985040
Savinainen KJ et al. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. 2004 Br. J. Cancer pmid:14997205
Adam PJ et al. CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. 2006 Br. J. Cancer pmid:16892042
Horiguchi J et al. Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer. 2002 Br. J. Cancer pmid:11870510
Kang MK et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. 2007 Br. J. Cancer pmid:17179983
Ivarsson K et al. Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. 2005 Br. J. Cancer pmid:16091763
Jhavar S et al. Construction of tissue microarrays from prostate needle biopsy specimens. 2005 Br. J. Cancer pmid:16091762
Theodore Ch et al. Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. 2004 Br. J. Cancer pmid:14710206
Myers E et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. 2004 Br. J. Cancer pmid:15477868
Cen L et al. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. 2007 Br. J. Cancer pmid:17848913
Stoeltzing O et al. Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. 2002 Br. J. Cancer pmid:12402160
Lopez-Crapez E et al. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. 2005 Br. J. Cancer pmid:15956964
Yuen HF et al. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. 2007 Br. J. Cancer pmid:18000500
Senapati S et al. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. 2008 Br. J. Cancer pmid:18781152
Nagourney RA et al. Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics. 2003 Br. J. Cancer pmid:14583785
Kristiansen G et al. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. 2008 Br. J. Cancer pmid:18781151
Takayama O et al. Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. 2006 Br. J. Cancer pmid:16969348
Griffiths EA et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. 2007 Br. J. Cancer pmid:17179985
Wülfing P et al. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. 2005 Br. J. Cancer pmid:15841074
Vernimmen D et al. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. 2003 Br. J. Cancer pmid:12942124
Kornfeld JW et al. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. 2011 Br. J. Cancer pmid:21102583
Cooper R et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? 2003 Br. J. Cancer pmid:12942120
Seynhaeve AL et al. Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. 2002 Br. J. Cancer pmid:11953868
Zvereff V et al. Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells. 2007 Br. J. Cancer pmid:17848953
Epping MT et al. PRAME expression and clinical outcome of breast cancer. 2008 Br. J. Cancer pmid:18648365
Maréchal R et al. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. 2009 Br. J. Cancer pmid:19352387
Xue SA et al. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? 2003 Br. J. Cancer pmid:12838311
Cellai I et al. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells. 2006 Br. J. Cancer pmid:16969347